90 related articles for article (PubMed ID: 19551812)
1. Analysis of genomic dose-response information on arsenic to inform key events in a mode of action for carcinogenicity.
Gentry PR; McDonald TB; Sullivan DE; Shipp AM; Yager JW; Clewell HJ
Environ Mol Mutagen; 2010 Jan; 51(1):1-14. PubMed ID: 19551812
[TBL] [Abstract][Full Text] [Related]
2. D-Serine exposure resulted in gene expression changes indicative of activation of fibrogenic pathways and down-regulation of energy metabolism and oxidative stress response.
Soto A; DelRaso NJ; Schlager JJ; Chan VT
Toxicology; 2008 Jan; 243(1-2):177-92. PubMed ID: 18061331
[TBL] [Abstract][Full Text] [Related]
3. Time- and concentration-dependent changes in gene expression induced by benzo(a)pyrene in two human cell lines, MCF-7 and HepG2.
Hockley SL; Arlt VM; Brewer D; Giddings I; Phillips DH
BMC Genomics; 2006 Oct; 7():260. PubMed ID: 17042939
[TBL] [Abstract][Full Text] [Related]
4. Research toward the development of a biologically based dose response assessment for inorganic arsenic carcinogenicity: a progress report.
Clewell HJ; Thomas RS; Gentry PR; Crump KS; Kenyon EM; El-Masri HA; Yager JW
Toxicol Appl Pharmacol; 2007 Aug; 222(3):388-98. PubMed ID: 17499324
[TBL] [Abstract][Full Text] [Related]
5. Biomarkers in aquatic plants: selection and utility.
Brain RA; Cedergreen N
Rev Environ Contam Toxicol; 2009; 198():49-109. PubMed ID: 19253039
[TBL] [Abstract][Full Text] [Related]
6. Relationships between genomic, cell cycle, and mutagenic responses of TK6 cells exposed to DNA damaging chemicals.
Islaih M; Halstead BW; Kadura IA; Li B; Reid-Hubbard JL; Flick L; Altizer JL; Thom Deahl J; Monteith DK; Newton RK; Watson DE
Mutat Res; 2005 Oct; 578(1-2):100-16. PubMed ID: 16109433
[TBL] [Abstract][Full Text] [Related]
7. Gene expression profiling of responses to dimethylarsinic acid in female F344 rat urothelium.
Sen B; Wang A; Hester SD; Robertson JL; Wolf DC
Toxicology; 2005 Nov; 215(3):214-26. PubMed ID: 16122865
[TBL] [Abstract][Full Text] [Related]
8. Study of gene expression profiles in TK6 human cells exposed to DNA-oxidizing agents.
Platel A; Gervais V; Sajot N; Nesslany F; Marzin D; Claude N
Mutat Res; 2010 Jul; 689(1-2):21-49. PubMed ID: 20466008
[TBL] [Abstract][Full Text] [Related]
9. Genome-wide analysis of BEAS-2B cells exposed to trivalent arsenicals and dimethylthioarsinic acid.
Chilakapati J; Wallace K; Ren H; Fricke M; Bailey K; Ward W; Creed J; Kitchin K
Toxicology; 2010 Jan; 268(1-2):31-9. PubMed ID: 19945496
[TBL] [Abstract][Full Text] [Related]
10. The effect of arsenicals on ultraviolet-radiation-induced growth arrest and related signaling events in human keratinocytes.
Mudipalli A; Owen RD; Preston RJ
Int J Oncol; 2005 Sep; 27(3):769-78. PubMed ID: 16077927
[TBL] [Abstract][Full Text] [Related]
11. Arsenic, mode of action at biologically plausible low doses: what are the implications for low dose cancer risk?
Snow ET; Sykora P; Durham TR; Klein CB
Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):557-64. PubMed ID: 15996700
[TBL] [Abstract][Full Text] [Related]
12. Identification of interspecies concordance of mechanisms of arsenic-induced bladder cancer.
Sen B; Wolf DC; Turpaz Y; Bugrim A; Retief J; Hester SD
Toxicol In Vitro; 2007 Dec; 21(8):1513-29. PubMed ID: 17720352
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia down-regulates DNA double strand break repair gene expression in prostate cancer cells.
Meng AX; Jalali F; Cuddihy A; Chan N; Bindra RS; Glazer PM; Bristow RG
Radiother Oncol; 2005 Aug; 76(2):168-76. PubMed ID: 16026872
[TBL] [Abstract][Full Text] [Related]
14. Arsenic trioxide-mediated growth inhibition in MC/CAR myeloma cells via cell cycle arrest in association with induction of cyclin-dependent kinase inhibitor, p21, and apoptosis.
Park WH; Seol JG; Kim ES; Hyun JM; Jung CW; Lee CC; Kim BK; Lee YY
Cancer Res; 2000 Jun; 60(11):3065-71. PubMed ID: 10850458
[TBL] [Abstract][Full Text] [Related]
15. Elimination of the differential chemoresistance between the murine B-cell lymphoma LY-ar and LY-as cell lines after arsenic (As2O3) exposure via the overexpression of gsto1 (p28).
Giri U; Terry NH; Kala SV; Lieberman MW; Story MD
Cancer Chemother Pharmacol; 2005 Jun; 55(6):511-21. PubMed ID: 15761769
[TBL] [Abstract][Full Text] [Related]
16. Cellular response to 5-fluorouracil (5-FU) in 5-FU-resistant colon cancer cell lines during treatment and recovery.
De Angelis PM; Svendsrud DH; Kravik KL; Stokke T
Mol Cancer; 2006 May; 5():20. PubMed ID: 16709241
[TBL] [Abstract][Full Text] [Related]
17. Arsenic trioxide-induced transcriptional activation of stress genes and expression of related proteins in human liver carcinoma cells (HepG2).
Tchounwou PB; Yedjou CG; Dorsey WC
Cell Mol Biol (Noisy-le-grand); 2003 Nov; 49(7):1071-9. PubMed ID: 14682389
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of Hsp90 inhibition for induction of apoptosis and inhibition of growth in cervical carcinoma cells in vitro and in vivo.
Schwock J; Pham NA; Cao MP; Hedley DW
Cancer Chemother Pharmacol; 2008 Apr; 61(4):669-81. PubMed ID: 17579866
[TBL] [Abstract][Full Text] [Related]
19. The cytostatic and cytotoxic effects of oridonin (Rubescenin), a diterpenoid from Rabdosia rubescens, on tumor cells of different lineage.
Chen S; Gao J; Halicka HD; Huang X; Traganos F; Darzynkiewicz Z
Int J Oncol; 2005 Mar; 26(3):579-88. PubMed ID: 15703811
[TBL] [Abstract][Full Text] [Related]
20. Comparison of gene expression in HCT116 treatment derivatives generated by two different 5-fluorouracil exposure protocols.
De Angelis PM; Kravik KL; Tunheim SH; Haug T; Reichelt WH
Mol Cancer; 2004 Apr; 3():11. PubMed ID: 15109396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
